InvestSMART

PharmX Technologies Limited (ASX: PHX) - Share Price

- Current share price for PHX : $0.069

Pharmx Technologies Limited (PHX) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a pharmacy ordering platform, providing essential infrastructure for seamless ordering and inventory management. By connecting the largest network of pharmacies, suppliers, and technology vendors, Pharmx facilitates $20bn in transactions annually through its robust, availability technology platform-driving efficient operations, seamless connectivity, and valuable insights across its ordering, eInvoicing, and analytics solutions.

PHX General Information +

ASX Code PHX
Website N/A
Industry/Sector Application Software
Market Cap ($M) 46
PHX Share Price $0.069
Day High $0.000
Day Low $0.000
Last Close $0.069
PHX Share Price Movement - ( No change )
Prices as at 16:40, 18 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

PharmX Technologies Limited (PHX) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Result 0.5¢ 30% 11 Feb 2015 23 Feb 2015 - - -
HFResult 0.6¢ 0% 11 Aug 2014 25 Aug 2014 - - -

See all dividends from PharmX Technologies Limited (PHX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

PharmX Technologies Limited (PHX) price-sensitive announcements

PHX - FY26 Results Presentation
Pharmx Technologies Limited’s FY26 Results Presentation outlines a year of platform execut
PharmX Technologies Limited (PHX)
27 Aug 2026 | 8:57 AM
PHX - Announcement of FY26 Results
Pharmx Technologies Limited announced its FY26 results for the year ended 30 June 2026, re
PharmX Technologies Limited (PHX)
27 Aug 2026 | 8:56 AM
PHX - Appendix 4E & FY26 Annual Report
Pharmx Technologies Limited’s Appendix 4E and FY26 Annual Report for the year ended 30 Jun
PharmX Technologies Limited (PHX)
27 Aug 2026 | 8:53 AM
PHX - H1 FY26 Investor Presentation
PharmX Technologies Limited, trading as PHX, reported a 3% revenue growth for the half-yea
PharmX Technologies Limited (PHX)
25 Feb 2026 | 8:32 AM

PharmX Technologies Limited (PHX) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
PharmX Technologies Limited (PHX)
ORDINARY FULLY PAID
Information Technology $46 Change of Company Secretary 27 Oct 2026 3:42PM $0.070 $0.069 fallen by 1.43%
PharmX Technologies Limited (PHX)
ORDINARY FULLY PAID
Information Technology $46 Notice of Annual General Meeting & Proxy Form 23 Oct 2026 9:32AM $0.072 $0.069 fallen by 4.17%
PharmX Technologies Limited (PHX)
ORDINARY FULLY PAID
Information Technology $46 Initial Director's Interest Notice - T Culver 21 Oct 2026 3:38PM $0.070 $0.069 fallen by 1.43%
PharmX Technologies Limited (PHX)
ORDINARY FULLY PAID
Information Technology $46 Director Appointment 16 Oct 2026 9:48AM $0.084 $0.069 fallen by 17.86%
PharmX Technologies Limited (PHX)
ORDINARY FULLY PAID
Information Technology $46 Q1 FY27 Investor Presentation 14 Oct 2026 9:46AM $0.084 $0.069 fallen by 17.86%
PharmX Technologies Limited (PHX)
ORDINARY FULLY PAID
Information Technology $46 Q1 FY27 Investor Update 12 Oct 2026 9:58AM $0.089 $0.069 fallen by 22.47%

PHX Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A -$1.83 -$0.30 625.00% 0.00 0.00 0.00% 0.0%
2025A -$0.26 N2 -136.40% 0.00 0.00 0.00% 0.0%
2024A $0.65 $0.10 -466.70% 34.30 0.00 0.00% 0.0%

PHX Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
Life360 Inc (360) $3,735M -32.1265 -0.6628 0.7080 21.6460 64.1870 37.5796 0.00% 0.00% 0.00%
PharmX Technologies Limited (PHX) $46M 6.2500 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Technology One Limited (TNE) $11,507M 0.1903 0.2021 0.2050 70.7671 58.8679 48.8534 1.15% 1.20% 1.45%
Wisetech Global Limited (WTC) $15,912M 0.0723 0.2838 0.3255 41.5036 32.3288 24.3904 0.48% 0.68% 0.94%
Xero Limited (XRO) $14,091M 0.0000 0.0000 0.6022 0.0000 76.2927 47.6185 0.00% 0.00% 0.00%

PHX Directors

Name Position Start Date
Mr Tom Culver Chief Executive Officer, Executive Director 15 Oct 2026
Mr Andrew Jonathan (Jon) George Newbery Executive Director, Interim CFO 25 Feb 2020
Mr Nick England Non-Executive Chairman, Non-Executive Director 21 Nov 2019
Ms Jayne Andrea Shaw Non-Executive Director 15 Oct 2020
Mr Alexander (Sandy) Richmond Mellis Non-Executive Director 1 Sep 2025
Mr Mark Conway Non-Executive Director 13 Mar 2026

PharmX Technologies Limited (PHX) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
12 Feb 2024 ENGLAND, Nick Buy Indirect Shares 127,500 $0.015 $1,912.500
11 Dec 2020 NEWBERY, Jon Buy Direct Shares 107,526 $0.098 $10,548.301
11 Dec 2020 NEWBERY, Jon Buy Indirect Shares 265,957 $0.098 $26,090.382

See all changes in directors' interest & trades for PharmX Technologies Limited (PHX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

PHX Management

Name Position
Zoe Hillier CFO
Andrew Kabega Company Secretary

PHX Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (PHX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
100,744,502 (15.12%) BNP Paribas Nominees Pty Ltd
76,512,556 (11.49%) BNP Paribas Nominees Pty Ltd <IB AU Noms Retail Client DRP>
66,611,866 (10%) CW Retail Holdings Pty Ltd
60,000,000 (9.01%) Arrotex Investments Holding 1
33,625,922 (5.05%) BNP Paribas Nominees Pty Ltd

PHX Calendar of Events

Date Event
26 August 2027 Report (Annual)
26 August 2027 Report (Prelim)
24 February 2027 Report (Interim)
25 November 2026 AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.